SynergEyes expands Duette progressive lens parameters

SynergEyes, Inc. has expanded parameters for its Duette Progressive lens, which is now available in 0.1 mm increments.

Carlsbad, CA-SynergEyes, Inc. has expanded parameters for its Duette Progressive lens, which is now available in 0.1 mm increments.

According to the company, a survey of 600 ODs verified the need for a high-performance contact lens for astigmatic presbyopes.  

3 correction options for presbyopes

“The vast majority of doctors said the most positive impact on their practices would be a better contact lens for astigmatic presbyopes. Expanding parameters of the Duette Progressive lens to 0.1mm increments will allow practitioners to optimize visual outcomes more successfully for even more patients,” said SynergEyes President and CEO James K. Kirchner, OD.

Utilizing a near center aspheric add zone in combination with a distance asphere, Duette Progressive provides a seamless progression of powers from distance to near, giving presbyopes GP vision at all distances along with soft lens comfort, according to the company. With a choice of three add powers to give the practitioner greater control over the visual outcome, Duette Progressive is an option for presbyopes with astigmatism and is also an ideal choice for moderate to advanced presbyopes who no longer get acceptable near vision from soft multifocal contact lenses. The lens also features an 84 Dk silicone hydrogel skirt around the 130 Dk center, and includes UV-blocking materials.

Related Videos
 Valerie M. Kattouf, OD, associate professor of optometry and chief of the Dr. Robert and Lena Lewenson Center for Pediatric and Binocular Vision, Illinois College of Optometry, speaks with Optometry Times®' Alex Delaney-Gesing on key highlights and takeaways from her 2022 Vision Expo West presentation titled "Myopia Control."
Ashley Tucker, OD, FAAO, FSLS, Dipl ABO, shares highlights from her discussion titled, "Myopia management: past, present, and future," presented during this year's 115th annual SCOPA meeting.
© 2023 MJH Life Sciences

All rights reserved.